"The Mechanic" Cellular Energy Optimization Protocol

Your cells make energy the same way they always have. But the machinery doing that work degrades over time, and it degrades in three specific places, which means fixing it requires three specific approaches in a specific order.

Before you can understand why the order matters, you need the map.

Inside almost every cell you have structures called mitochondria, which are the sites where your body converts food into a usable energy currency called ATP. That conversion happens through a sequence of protein complexes embedded in the inner mitochondrial membrane, something called the electron transport chain. Electrons from the food you eat get passed down this chain like a bucket brigade, and that movement pumps protons across the membrane, and the flow of those protons back through a final protein called ATP synthase is what actually manufactures ATP. The whole system runs on a membrane that has to stay tightly organized and on mobile carrier molecules that shuttle electrons between the complexes.

That is the machine. Now here is how it breaks.

The first failure point is the membrane itself. The inner mitochondrial membrane is built around a specialized phospholipid called cardiolipin, which does something structurally important. Cardiolipin anchors the protein complexes of the electron transport chain and holds them in the precise geometry they need to pass electrons efficiently. As you age, cardiolipin gets oxidized and degraded, the complexes lose their organization, and electrons start leaking out of the chain before they can do useful work. Leaked electrons react with oxygen to form reactive oxygen species, which damage the membrane further, which accelerates the degradation of cardiolipin. It is a self-reinforcing cycle, and it means that even before you address anything else, you are working with a compromised physical structure.

The second failure point is the fuel supply for a completely different system. Your cells use a molecule called NAD+, which is a coenzyme that sits at the center of dozens of reactions including energy metabolism, DNA repair, and the activation of proteins called sirtuins that regulate cellular maintenance. NAD+ levels drop significantly with age, and for a long time the explanation was simply that production slows down. That part is true. But research published in 2016 and 2020 identified a more active mechanism. An enzyme called CD38, which degrades NAD+ as part of its normal function, increases in activity two to three fold as you age. And the reason it increases is that senescent cells, which are cells that have stopped dividing but refuse to die, secrete a cocktail of inflammatory signals that cause CD38-expressing macrophages to accumulate in your tissues. More CD38 means faster NAD+ degradation, which means the deficit is not just a production problem. There is an accelerating drain.

The third failure point connects to both of the first two. As the machinery becomes less efficient and the maintenance systems become less functional, the cell itself becomes less capable of adapting. This is where the protocol structure starts to make sense, because you cannot optimize a broken machine and you cannot repair a machine that is still being actively sabotaged.

So the sequence runs: stabilize the membrane, clear the senescent cells driving the drain, restore and optimize what remains.

The first compound in the repair phase is SS-31, a synthetic peptide that selectively binds to cardiolipin on the inner mitochondrial membrane. The binding is not random. SS-31 has an alternating aromatic-cationic structure that gives it a strong affinity specifically for cardiolipin, so it concentrates exactly where the structural damage is happening. By stabilizing cardiolipin, it restores the organized geometry the protein complexes need, reduces electron leakage, and cuts the downstream production of reactive oxygen species. Research published in the Journal of the American Society of Nephrology showed that this stabilization re-energizes mitochondria at the level of the membrane itself, not just by adding more substrate to a broken system.

Once the membrane is more stable, the next target is the senescent cell population. FOXO4-DRI is a peptide that disrupts the specific protein interaction keeping senescent cells alive. In healthy cells, a protein called p53 would normally trigger apoptosis, the cell's programmed death sequence. But in senescent cells, a transcription factor called FOXO4 binds p53 and holds it away from the mitochondria where it needs to go to initiate that sequence. FOXO4-DRI mimics the FOXO4 binding domain, competes for that interaction, and frees p53 to do its job. The 2017 Cell paper that characterized this mechanism reported 11.73-fold selectivity for senescent cells over healthy cells, which matters because a senolytic that damages healthy tissue to clear damaged tissue is not a net gain.

This is also where the temporary discomfort during the protocol comes from. When senescent cells clear at scale, the immune system is actively removing biological debris, and that process has a systemic cost for a few days.

Epithalon enters next, and its primary characterized mechanism is in telomere biology rather than mitochondrial function directly. Research showed it induces expression of hTERT, which is the catalytic component of telomerase, the enzyme that maintains telomere length in dividing cells. The peptide also appears to restore melatonin rhythm disrupted by aging, with studies in aged primates showing the synthetic tetrapeptide produced equivalent hormonal restoration to the original pineal extract at roughly 500-fold lower dose. Its role in this protocol is cellular maintenance support during the transition out of the repair phase.

MOTS-c is where the optimization begins. It is a peptide encoded within the mitochondrial genome itself, which makes it structurally different from the other compounds here. It works by inhibiting an enzyme in what is called the folate cycle, which causes a buildup of a metabolite called AICAR, and AICAR activates AMPK, something called AMP-activated protein kinase, which functions as the cell's energy sensor and efficiency regulator. When AMPK is activated, the cell upregulates glucose uptake, shifts toward more efficient metabolic pathways, and increases mitochondrial biogenesis. The 2015 Cell Metabolism study found MOTS-c prevented diet-induced insulin resistance and obesity in mice, but the mechanism is the relevant part: it is not adding more raw material to the system, it is telling repaired mitochondria to work more efficiently.

The NAD+ component of the protocol is worth addressing directly because this is where a lot of money gets spent on the wrong thing. NMN and NR, which are the popular oral precursors, undergo conversion in the gut before absorption. Research published in 2020 and confirmed in 2025 showed that most oral NMN and NR is deamidated by gut bacteria into nicotinic acid, which is just niacin, before it reaches systemic circulation. The gut is essentially converting the expensive precursor into the cheap one. Plain niacin works because it enters the same biosynthetic pathway. And separately, NAMPT, the rate-limiting enzyme in the main NAD+ synthesis pathway, increased 127% in sedentary subjects after an exercise training intervention, which means exercise is doing something to NAD+ metabolism that no supplement replicates at that magnitude.

L-carnitine is the one molecule capable of transporting long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. If your cells are increasingly reliant on fat as a substrate, which they are as mitochondrial efficiency improves, carnitine availability becomes a genuine bottleneck. Injectable L-carnitine bypasses the absorption ceiling that limits oral dosing.

The ordering of this protocol exists because the system has an ordering. You cannot optimize a membrane that is still degrading. You cannot fully benefit from NAD+ restoration while senescent cells are driving CD38 activity up. And MOTS-c pushing increased mitochondrial output through AMPK activation is only useful if the machinery it is pushing has been structurally restored first.

Most energy interventions try to add more fuel to a leaking engine. This one starts by fixing the leak.

---

References

1. Birk AV, Liu S, Soong Y, et al. The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin. Journal of the American Society of Nephrology. 2013;248:1250-1261. Finding: SS-31 selectively binds cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure. Source
2. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology. 2014;1718:2029-2050. Finding: SS-31 binds cardiolipin, stabilizes mitochondrial membrane structure, and reduces electron leakage and ROS production. Source
3. Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;1691:132-147. Finding: FOXO4-DRI disrupts FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis. 11.73-fold selectivity for senescent vs healthy cells. Source
4. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age. CD38 knockout mice maintained NAD+ levels at all ages. Source
5. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cell SASP cytokines induce macrophages to upregulate CD38, establishing the causal chain from senescence to NAD+ decline. Source
6. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. 2003;1356:590-592. Finding: Epithalon induced hTERT expression, telomerase activity, and telomere elongation in human fibroblasts. Source
7. Goncharova ND, Vengerin AA, Khavinson VKh, Lapin BA. Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas. Experimental Gerontology. 2005;401-2:51-57. Finding: Epithalamin at 5mg/day and synthetic Epithalon at 10mcg/day achieved equivalent melatonin restoration in aged monkeys, demonstrating 500-fold potency difference. Source
8. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;213:443-454. Finding: MOTS-c activates AMPK via inhibition of the folate cycle. Prevented insulin resistance and diet-induced obesity. Source
9. Shats I, Williams JG, Liu J, et al. Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway. Cell Metabolism. 2020;313:564-579. Finding: Gut bacteria deamidate nicotinamide to nicotinic acid niacin, confirming NMN/NR undergo gut conversion before absorption. Source
10. Kim LJ, et al. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation. Science Advances. 2025. Finding: Most oral NMN and NR is converted to niacin-pathway metabolites in the gut before absorption. Source
11. Costford SR, Bajpeyi S, Pasarica M, et al. Skeletal muscle NAMPT is induced by exercise in humans. American Journal of Physiology - Endocrinology and Metabolism. 2010;2981:E117-E126. Finding: NAMPT protein increased 127% in sedentary subjects after exercise training. Source
12. Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochimica et Biophysica Acta. 2016;186310:2422-2435. Finding: L-carnitine is the sole molecule carrying long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Source
13. Banerjee R, Purhonen J, Bhardwaj R, Bhargava A, Kallijarvi J. The mitochondrial coenzyme Q junction and complex III. The FEBS Journal. 2022;28922:6936-6958. Finding: CoQ serves as the mobile electron carrier between Complex I/II and Complex III. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness